David C. Bupp
2009
In 2009, David C. Bupp earned a total compensation of $953.9K as President and Chief Executive Officer at Navidea Biopharmaceuticals, a 77% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $45,000 |
|---|---|
| Salary | $335,000 |
| Stock Awards | $565,308 |
| Other | $8,621 |
| Total | $953,929 |
Bupp received $565.3K in stock awards, accounting for 59% of the total pay in 2009.
Bupp also received $45K in non-equity incentive plan, $335K in salary and $8.6K in other compensation.
Rankings
In 2009, David C. Bupp's compensation ranked 4,618th out of 9,885 executives tracked by ExecPay. In other words, Bupp earned more than 53.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,618 out of 9,885 | 53rd |
Division Manufacturing | 1,646 out of 3,690 | 55th |
Major group Chemicals And Allied Products | 327 out of 866 | 62nd |
Industry group Drugs | 199 out of 638 | 69th |
Industry In Vitro and In Vivo Diagnostic Substances | 10 out of 44 | 77th |
Source: SEC filing on July 10, 2012.
Bupp's colleagues
We found three more compensation records of executives who worked with David C. Bupp at Navidea Biopharmaceuticals in 2009.